Acquiring Company
Ayrmid Ltd
Acquired Company
Karyopharm Therapeutics
NewtonBiotechnologyHealthcareDescription
Karyopharm Therapeutics entered a Restructuring Support Agreement with its lenders providing for a merger with Ayrmid Ltd. through a Chapter 11 plan. Ayrmid will serve as lead bidder in a court-supervised sale process in the Southern District of Texas, where competing bids may be submitted. The transaction is expected to close in the first quarter of 2027, and the company has secured up to $55 million in DIP financing.
Who to call at Ayrmid Ltd, and when
When Ayrmid Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Ayrmid Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ayrmid Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ayrmid Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ayrmid Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Karyopharm Therapeutics?
Karyopharm Therapeutics was acquired by Ayrmid Ltd. The deal was reported on November 2, 2026. Ayrmid Ltd is involved in investments focusing on the biopharmaceutical industry. They aim to enhance the capabilities of acquired companies through strategic funding. Ayrmid Ltd is privately held and operates in Biotechnology.
When did Ayrmid Ltd acquire Karyopharm Therapeutics?
Ayrmid Ltd's acquisition of Karyopharm Therapeutics was reported on November 2, 2026. Karyopharm Therapeutics entered a Restructuring Support Agreement with its lenders providing for a merger with Ayrmid Ltd. through a Chapter 11 plan. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Karyopharm Therapeutics do?
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. It is publicly traded (KPTI), operating in Healthcare, and is based in Newton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.